Over 1,000 Women Worldwide Have Now Received Motiva Breast Implants with VeriTeQ’s Q Inside Safety Technology
September 16 2014 - 9:39AM
Business Wire
Geographic adoption continues in Europe, Latin
America and Asia
VeriTeQ Corporation (“VeriTeQ”) (OTC Markets: VTEQ), a provider
of implantable medical device identification and radiation dose
measurement technologies, announced today that more than 1,000
women worldwide have now received Motiva Implant Matrix® breast
implants with VeriTeQ’s Q Inside Safety Technology™. Motiva Implant
Matrix® breast implants, manufactured by Establishment Labs S.A.
(“EL”), featuring VeriTeQ’s Q Inside Safety Technology™ can be
safely and accurately identified from outside of the body in a
physician’s office.
VeriTeQ’s FDA cleared Q Inside Safety Technology™ acts as an
electronic serial number in breast implants and other implantable
and reusable medical devices to provide physicians and patients
access to secure online databases to retrieve device-specific data,
such as serial number, manufacturer name, date of manufacture, lot
number, volume, size, and other data from the medical device
manufacturer. Q Inside Safety Technology™ may also provide an extra
level of protection to the patient in the event of a recall or
other safety event.
EL’s Motiva Implant Matrix® Ergonomix™, VelvetSurface® PLUS, and
SilkSurface® PLUS, all with VeriTeQ’s Q Inside Safety Technology,
have received CE Mark approval.
“This is an important milestone for Motiva and a clear signal to
the industry that women value innovation and safety in long-term
implantable devices,” said Juan Jose Chacon-Quiros, Chief Executive
Officer of EL.
“We are very proud of the work we are doing with our partner
Establishment Labs to reach this significant milestone for our
medical device identification business,” said Scott R. Silverman,
VeriTeQ’s Chairman and Chief Executive Officer. “EL continues to
see increased demand for its best-in-class breast implants as both
physicians and patients request enhanced identification and other
advanced technology options for their medical devices.”
About VeriTeQ
VeriTeQ develops innovative, proprietary RFID technologies for
implantable medical device identification, and dosimeter
technologies for use in radiation therapy treatment. VeriTeQ offers
the world's first FDA cleared RFID microchip technology that can be
used to identify implantable medical devices, in vivo, on demand,
at the point of care. VeriTeQ's dosimeters provide patient safety
mechanisms while measuring and recording the dose of radiation
delivered to a patient in real time. For more information on
VeriTeQ, please visit www.veriteqcorp.com.
About EL
Establishment Labs is a privately held, global breast, body and
facial aesthetic company with offices in Florida, Costa Rica and
Belgium, that designs, develops, manufactures and markets an
innovative product portfolio consisting of advanced silicone-filled
breast (www.motivaimplants.com) and body shaping implants.
Utilizing only the highest quality of medical grade silicones, the
CE-marked Motiva Implant Matrix® line is rigorously scrutinized by
professional Quality Engineers throughout the entire manufacturing
process. All its products are manufactured in full compliance with
ISO and EU requirements, and are certified under the Medical Device
Directive 93/42/EEC. For more information on EL, please visit
www.establishmentlabs.com.
Statements in this press release about our future expectations,
including the likelihood that Q Inside Safety Technology may also
provide an extra level of protection to the patient in the event of
a recall or other safety event; constitute "forward-looking
statements" within the meaning of Section 27A of the Securities Act
of 1933, Section 21E of the Securities Exchange Act of 1934, and as
that term is defined in the Private Litigation Reform Act of 1995.
Such forward-looking statements involve risks and uncertainties and
are subject to change at any time, and our actual results could
differ materially from expected results. These risks and
uncertainties include, without limitation, VeriTeQ’s ability to
raise capital; as well as other risks. Additional information about
these and other factors may be described in VeriTeQ’s Form 10-K,
filed on April 15, 2014, and Forms 10-Q, filed on August 20, 2014,
May 14, 2014, and November 14, 2013, and future filings with the
Securities and Exchange Commission The Company undertakes no
obligation to update or release any revisions to these
forward-looking statements to reflect events or circumstances after
the date of this statement or to reflect the occurrence of
unanticipated events, except as required by law.
VeriTeQAllison Tomek, 561-846-7003atomek@veriteqcorp.com
VeriTeQ (CE) (USOTC:VTEQ)
Historical Stock Chart
From Apr 2024 to May 2024
VeriTeQ (CE) (USOTC:VTEQ)
Historical Stock Chart
From May 2023 to May 2024